OAYLX
Price
$83.67
Change
+$0.34 (+0.41%)
Updated
Jul 3 closing price
Net Assets
7.3B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

OAYLX vs VVIAX

Header iconOAYLX vs VVIAX Comparison
Open Charts OAYLX vs VVIAXBanner chart's image
Oakmark Select Advisor
Price$83.67
Change+$0.34 (+0.41%)
VolumeN/A
Net Assets7.3B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
OAYLX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OAYLX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OAYLX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. OAYLX (7.3B). VVIAX pays higher dividends than OAYLX: VVIAX (2.18) vs OAYLX (0.42). OAYLX was incepted earlier than VVIAX: OAYLX (9 years) vs VVIAX (25 years). OAYLX (0.87) is less costly to investors than VVIAX (0.05). OAYLX is a more actively managed with annual turnover of: 57.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than OAYLX: VVIAX (3000) vs OAYLX (100000). OAYLX annual gain was more profitable for investors over the last year : 19.70 vs. VVIAX (12.03). OAYLX return over 5 years is better than : 133.23 vs. VVIAX (80.13).
OAYLXVVIAXOAYLX / VVIAX
Total Expense Ratio0.870.051,740%
Annual Report Gross Expense Ratio0.870.051,740%
Fund Existence9 years25 years-
Gain YTD4.6406.19875%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets7.3B189B4%
Annual Yield % from dividends0.422.1819%
Returns for 1 year19.7012.03164%
Returns for 3 years65.3235.17186%
Returns for 5 years133.2380.13166%
Returns for 10 yearsN/A115.67-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.